Acasti Pharma Stock (NASDAQ:ACST)
Previous Close
$3.24
52W Range
$1.98 - $3.60
50D Avg
$3.05
200D Avg
$2.99
Market Cap
$34.17M
Avg Vol (3M)
$33.25K
Beta
1.52
Div Yield
-
ACST Company Profile
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
ACST Performance
Peer Comparison
| Ticker | Company |
|---|---|
| AKTX | Akari Therapeutics, Plc |
| JAGX | Jaguar Health, Inc. |
| MBRX | Moleculin Biotech, Inc. |
| ONTX | Traws Pharma, Inc. |
| PULM | Pulmatrix, Inc. |
| DFFN | CervoMed Inc. |
| TNXP | Tonix Pharmaceuticals Holding Corp. |
| CBIO | Gyre Therapeutics, Inc. |
| BPTH | Bio-Path Holdings, Inc. |
| ARDS | Aridis Pharmaceuticals, Inc. |
| OCGN | Ocugen, Inc. |
| GOVX | GeoVax Labs, Inc. |